FILTER
Refine your search with the following facets to narrow down your results.
- infectious diseases 13
- seasonal influenza 9
- avian influenza 8
- vaccine development 8
- H1N1 7
- antibodies 7
- influenza A 7
- viral infection 7
- immune system 6
- mRNA vaccines 6
- medicine 6
- HIV 5
- SARS-CoV-2 5
- antiviral drugs 5
- flu vaccines 5
- infections 5
- pandemic influenza 5
- vaccination 5
- AIDS 4
- CureVac 4
- H5N1 4
- bacteria 4
- clinical trials 4
- diagnostics 4
- immune cells 4
- influenza vaccines 4
- inhibitors 4
- viral diseases 4
- H3N2 3
- RNA 3
- epidemics 3
- hemagglutinin 3
- hepatitis 3
- immunology 3
- inflammation 3
- laboratories 3
- monoclonal antibodies 3
- peptides 3
- phase I studies 3
- pneumonia 3
- proteins 3
- respiratory infections 3
- therapeutics 3
- virology 3
- virus-like particles 3
- zika 3
- Ebola 2
- Evolva 2
- Expression 2
- RNA viruses 2
- Sanofi Pasteur 2
- West Nile Virus 2
- aerosols 2
- antibiotics 2
- antiviral therapies 2
- bacterial infections 2
- biotechnology 2
- blood tests 2
- bone marrow 2
- capsids 2
- chemical engineering 2
- cryo-electron microscopy 2
- cytokines 2
- diagnosis 2
- diseases 2
- financing 2
- genome sequencing 2
- hepatitis C 2
- humidity 2
- interferon 2
- macrophages 2
- measles 2
- microbiology 2
- mutations 2
- oseltamivir 2
- pandemic 2
- phase II studies 2
- respiratory diseases 2
- seed financing 2
- 3D printing 1
- Akzo Nobel 1
- Alnylam 1
- Brazil 1
- CRISPR 1
- Chlamydia 1
- Chlamydia trachomatis 1
- Creutzfeldt-Jakob disease 1
- Crucell 1
- Doxycycline 1
- Frost & Sullivan 1
- Generex Biotechnology 1
- High-Tech Gründerfonds Management 1
- Intercell 1
- Lawesson’s Reagent 1
- Lebanon 1
- Atriva Therapeutics GmbH 5
- High-Tech Gründerfonds Management GmbH 5
- CureVac AG 4
- Eidgenössische Technische Hochschule Zürich (ETH Zürich) 3
- sanofi-aventis Groupe 3
- Association for Professionals in Infection Control and Epidemiology, Inc. (APIC) 2
- Capital MS&L Limited 2
- Evolva SA 2
- Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. 2
- National Institute of Allergy and Infectious Diseases (NIAID) 2
- Novavax, Inc. 2
- Paul-Ehrlich-Institut (PEI) 2
- The Johns Hopkins University 2
- The Pennsylvania State University 2
- University of Florida 2
- University of North Carolina at Chapel Hill 2
- Universität Zürich 2
- b3c communications 2
- A. Lavin Communications 1
- Agency for Science, Technology and Research (A*STAR) 1
- Albert-Ludwigs-Universität Freiburg 1
- Alnylam Pharmaceuticals, Inc. 1
- American Society For Microbiology 1
- Angewandte Chemie 1
- Avir Green Hills Biotechnology AG 1
- Beactica AB 1
- Ben-Gurion University of the Negev 1
- BioMed Central Ltd 1
- Brigham Young University 1
- CSL Limited 1
- Centers for Disease Control and Prevention (CDC) 1
- Crucell N.V. 1
- Duke University 1
- Ecole Polytechnique Fédérale de Lausanne (EPFL) 1
- Emory University 1
- Emory University Medical School 1
- European Molecular Biology Laboratory (EMBL) 1
- Fonds zur Förderung der wissenschaftlichen Forschung (FWF) 1
- Frost & Sullivan 1
- Generex Biotechnology Corporation 1
- Georgia State University 1
- GlaxoSmithKline plc (GSK) 1
- GlobalData 1
- Harvard Medical School 1
- Helmholtz-Zentrum für Infektionsforschung GmbH 1
- Icahn School of Medicine at Mount Sinai 1
- Immune Targeting Systems 1
- ImmuneMed Inc. 1
- Infectious Diseases Society of America (IDSA) 1
- Institut Pasteur 1
- Intercell AG 1
- International Society for Interferon and Cytokine Research 1
- John Wiley & Sons, Inc. 1
- Kanazawa University 1
- Karolinska Institutet 1
- Leibniz-Institut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP) 1
- London School of Hygiene & Tropical Medicine 1
- Lonza Group Ltd 1
- M: Communications 1
- MC Services AG 1
- Max-Planck-Institut für Entwicklungsbiologie 1
- Max-Planck-Institut für Infektionsbiologie 1
- McMaster University 1
- Medizinische Universität Wien 1
- Meridian Life Science, Inc. 1
- Mucosis B.V. 1
- N.V. Organon 1
- Nanogen, Inc. 1
- Nobilon International BV 1
- North Carolina State University 1
- Novartis International AG 1
- Otto-von-Guericke-Universität Magdeburg 1
- OxDX Ltd. 1
- PBL InterferonSource 1
- Pfizer Inc. 1
- Pharmacelsus GmbH 1
- Pike Pharma GmbH 1
- Public Library of Science (PLoS) 1
- Queen's University Belfast 1
- Robert Bosch GmbH 1
- Ruhr-Universität Bochum 1
- Rutgers, The State University of New Jersey 1
- SEEK 1
- Sanofi Pasteur SA 1
- Sea Lane Biotechnologies, LLC 1
- Senckenberg Gesellschaft für Naturforschung 1
- Stanford University 1
- Swedish Institute for Infectious Disease Control 1
- Talecris Biotherapeutics, Inc. 1
- The Howard Hughes Medical Institute (HHMI) 1
- The Rockefeller University 1
- The Scripps Research Institute (TSRI) 1
- U. S. Food and Drug Administration (FDA) 1
- Umeå universitet 1
- University of Alabama, Birmingham (UAB) 1
- University of British Columbia (UBC) 1
- University of California, Santa Cruz 1
- University of Cambridge 1
- University of Edinburgh 1
- University of Notre Dame 1
- University of Pennsylvania 1
- University of Pittsburgh 1
- University of Rochester 1
- University of Texas Southwestern Medical Center 1
- University of Texas at Austin 1
- University of Utah 1
- University of Washington 1
- Università degli Studi di Roma Tor Vergata 1
- Universität Basel 1
- Universität Wien 1
- Université de Genève 1
- Uppsala University 1
- Vironova AB 1
- WILEY-VCH GmbH 1
- Washington University 1
- Westfälische Wilhelms-Universität Münster 1
- Yale University 1
- Zyme Communications Ltd 1
103 Current news about the topic influenza
FILTERS
Refine your search with the following facets to narrow down your results.
- infectious diseases 13
- seasonal influenza 9
- avian influenza 8
- vaccine development 8
- H1N1 7
- antibodies 7
- influenza A 7
- viral infection 7
- immune system 6
- mRNA vaccines 6
- medicine 6
- HIV 5
- SARS-CoV-2 5
- antiviral drugs 5
- flu vaccines 5
- infections 5
- pandemic influenza 5
- vaccination 5
- AIDS 4
- CureVac 4
- H5N1 4
- bacteria 4
- clinical trials 4
- diagnostics 4
- immune cells 4
- influenza vaccines 4
- inhibitors 4
- viral diseases 4
- H3N2 3
- RNA 3
- epidemics 3
- hemagglutinin 3
- hepatitis 3
- immunology 3
- inflammation 3
- laboratories 3
- monoclonal antibodies 3
- peptides 3
- phase I studies 3
- pneumonia 3
- proteins 3
- respiratory infections 3
- therapeutics 3
- virology 3
- virus-like particles 3
- zika 3
- Ebola 2
- Evolva 2
- Expression 2
- RNA viruses 2
- Sanofi Pasteur 2
- West Nile Virus 2
- aerosols 2
- antibiotics 2
- antiviral therapies 2
- bacterial infections 2
- biotechnology 2
- blood tests 2
- bone marrow 2
- capsids 2
- chemical engineering 2
- cryo-electron microscopy 2
- cytokines 2
- diagnosis 2
- diseases 2
- financing 2
- genome sequencing 2
- hepatitis C 2
- humidity 2
- interferon 2
- macrophages 2
- measles 2
- microbiology 2
- mutations 2
- oseltamivir 2
- pandemic 2
- phase II studies 2
- respiratory diseases 2
- seed financing 2
- 3D printing 1
- Akzo Nobel 1
- Alnylam 1
- Brazil 1
- CRISPR 1
- Chlamydia 1
- Chlamydia trachomatis 1
- Creutzfeldt-Jakob disease 1
- Crucell 1
- Doxycycline 1
- Frost & Sullivan 1
- Generex Biotechnology 1
- High-Tech Gründerfonds Management 1
- Intercell 1
- Lawesson’s Reagent 1
- Lebanon 1
- Atriva Therapeutics GmbH 5
- High-Tech Gründerfonds Management GmbH 5
- CureVac AG 4
- Eidgenössische Technische Hochschule Zürich (ETH Zürich) 3
- sanofi-aventis Groupe 3
- Association for Professionals in Infection Control and Epidemiology, Inc. (APIC) 2
- Capital MS&L Limited 2
- Evolva SA 2
- Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. 2
- National Institute of Allergy and Infectious Diseases (NIAID) 2
- Novavax, Inc. 2
- Paul-Ehrlich-Institut (PEI) 2
- The Johns Hopkins University 2
- The Pennsylvania State University 2
- University of Florida 2
- University of North Carolina at Chapel Hill 2
- Universität Zürich 2
- b3c communications 2
- A. Lavin Communications 1
- Agency for Science, Technology and Research (A*STAR) 1
- Albert-Ludwigs-Universität Freiburg 1
- Alnylam Pharmaceuticals, Inc. 1
- American Society For Microbiology 1
- Angewandte Chemie 1
- Avir Green Hills Biotechnology AG 1
- Beactica AB 1
- Ben-Gurion University of the Negev 1
- BioMed Central Ltd 1
- Brigham Young University 1
- CSL Limited 1
- Centers for Disease Control and Prevention (CDC) 1
- Crucell N.V. 1
- Duke University 1
- Ecole Polytechnique Fédérale de Lausanne (EPFL) 1
- Emory University 1
- Emory University Medical School 1
- European Molecular Biology Laboratory (EMBL) 1
- Fonds zur Förderung der wissenschaftlichen Forschung (FWF) 1
- Frost & Sullivan 1
- Generex Biotechnology Corporation 1
- Georgia State University 1
- GlaxoSmithKline plc (GSK) 1
- GlobalData 1
- Harvard Medical School 1
- Helmholtz-Zentrum für Infektionsforschung GmbH 1
- Icahn School of Medicine at Mount Sinai 1
- Immune Targeting Systems 1
- ImmuneMed Inc. 1
- Infectious Diseases Society of America (IDSA) 1
- Institut Pasteur 1
- Intercell AG 1
- International Society for Interferon and Cytokine Research 1
- John Wiley & Sons, Inc. 1
- Kanazawa University 1
- Karolinska Institutet 1
- Leibniz-Institut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP) 1
- London School of Hygiene & Tropical Medicine 1
- Lonza Group Ltd 1
- M: Communications 1
- MC Services AG 1
- Max-Planck-Institut für Entwicklungsbiologie 1
- Max-Planck-Institut für Infektionsbiologie 1
- McMaster University 1
- Medizinische Universität Wien 1
- Meridian Life Science, Inc. 1
- Mucosis B.V. 1
- N.V. Organon 1
- Nanogen, Inc. 1
- Nobilon International BV 1
- North Carolina State University 1
- Novartis International AG 1
- Otto-von-Guericke-Universität Magdeburg 1
- OxDX Ltd. 1
- PBL InterferonSource 1
- Pfizer Inc. 1
- Pharmacelsus GmbH 1
- Pike Pharma GmbH 1
- Public Library of Science (PLoS) 1
- Queen's University Belfast 1
- Robert Bosch GmbH 1
- Ruhr-Universität Bochum 1
- Rutgers, The State University of New Jersey 1
- SEEK 1
- Sanofi Pasteur SA 1
- Sea Lane Biotechnologies, LLC 1
- Senckenberg Gesellschaft für Naturforschung 1
- Stanford University 1
- Swedish Institute for Infectious Disease Control 1
- Talecris Biotherapeutics, Inc. 1
- The Howard Hughes Medical Institute (HHMI) 1
- The Rockefeller University 1
- The Scripps Research Institute (TSRI) 1
- U. S. Food and Drug Administration (FDA) 1
- Umeå universitet 1
- University of Alabama, Birmingham (UAB) 1
- University of British Columbia (UBC) 1
- University of California, Santa Cruz 1
- University of Cambridge 1
- University of Edinburgh 1
- University of Notre Dame 1
- University of Pennsylvania 1
- University of Pittsburgh 1
- University of Rochester 1
- University of Texas Southwestern Medical Center 1
- University of Texas at Austin 1
- University of Utah 1
- University of Washington 1
- Università degli Studi di Roma Tor Vergata 1
- Universität Basel 1
- Universität Wien 1
- Université de Genève 1
- Uppsala University 1
- Vironova AB 1
- WILEY-VCH GmbH 1
- Washington University 1
- Westfälische Wilhelms-Universität Münster 1
- Yale University 1
- Zyme Communications Ltd 1